Patents by Inventor Jing-Yu Lai

Jing-Yu Lai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11955336
    Abstract: Method of manufacturing a semiconductor device, includes forming a protective layer over substrate having a plurality of protrusions and recesses. The protective layer includes polymer composition including polymer having repeating units of one or more of: Wherein a, b, c, d, e, f, g, h, and i are each independently H, —OH, —ROH, —R(OH)2, —NH2, —NHR, —NR2, —SH, —RSH, or —R(SH)2, wherein at least one of a, b, c, d, e, f, g, h, and i on each repeating unit is not H. R, R1, and R2 are each independently a C1-C10 alkyl group, a C3-C10 cycloalkyl group, a C1-C10 hydroxyalkyl group, a C2-C10 alkoxy group, a C2-C10 alkoxy alkyl group, a C2-C10 acetyl group, a C3-C10 acetylalkyl group, a C1-C10 carboxyl group, a C2-C10 alkyl carboxyl group, or a C4-C10 cycloalkyl carboxyl group, and n is 2-1000. A resist layer is formed over the protective layer, and the resist layer is patterned.
    Type: Grant
    Filed: April 23, 2021
    Date of Patent: April 9, 2024
    Assignee: TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD.
    Inventors: Jing Hong Huang, Wei-Han Lai, Ching-Yu Chang
  • Publication number: 20150057431
    Abstract: The present invention provides methods of treating (including preventing) a disease or condition associated with abnormal angiogenesis in a subject include administering a therapeutically effective amount of an AA targeting compound of the invention to the subject. The AA targeting compounds comprise AA targeting agent-linker conjugates which are linked to a combining site of an antibody.
    Type: Application
    Filed: October 31, 2014
    Publication date: February 26, 2015
    Inventors: Curt William BRADSHAW, Abhijit Suresh BHAT, Jing-Yu LAI, Venkata R. DOPPALAPUDI, Dingguo LIU
  • Patent number: 8937048
    Abstract: The present invention provides various uses of VEGF binding peptides, including methods to treat disorders associated with abnormal angiogenesis. In addition, the invention provides VEGF peptides conjugated to antibodies alone and in conjunction with other anti-angiogenic molecules.
    Type: Grant
    Filed: August 27, 2012
    Date of Patent: January 20, 2015
    Assignee: Covx Technologies Ireland, Limited
    Inventors: Venkata Ramana Doppalapudi, Jing-Yu Lai, Bin Liu, Dingguo Liu, Joel Desharnais, Abhijit Suresh Bhat, Yanwen Fu, Bryan Douglas Oates, Gang Chen, Curt William Bradshaw
  • Patent number: 8912148
    Abstract: The present invention provides methods of treating (including preventing) a disease or condition associated with abnormal angiogenesis in a subject include administering a therapeutically effective amount of an AA targeting compound of the invention to the subject. The AA targeting compounds comprise AA targeting agent-linker conjugates which are linked to a combining site of an antibody.
    Type: Grant
    Filed: August 13, 2012
    Date of Patent: December 16, 2014
    Assignee: Covx Technology Ireland, Ltd.
    Inventors: Curt Bradshaw, Abhijit Bhat, Jing Yu Lai, Venkata Doppalapudi, Dingguo Liu
  • Publication number: 20120321591
    Abstract: The present invention provides various uses of VEGF binding peptides, including methods to treat disorders associated with abnormal angiogenesis.
    Type: Application
    Filed: August 27, 2012
    Publication date: December 20, 2012
    Inventors: Venkata Ramana Doppalapudi, Jing-Yu Lai, Bin Liu, Dingguo Liu, Joel Desharnais, Abhijit Suresh Bhat, Yanwen Fu, Bryan Douglas Oates, Gang Chen, Curt William Bradshaw
  • Publication number: 20120301431
    Abstract: The present invention provides methods of treating (including preventing) a disease or condition associated with abnormal angiogenesis in a subject include administering a therapeutically effective amount of an AA targeting compound of the invention to the subject. The AA targeting compounds comprise AA targeting agent-linker conjugates which are linked to a combining site of an antibody.
    Type: Application
    Filed: August 13, 2012
    Publication date: November 29, 2012
    Inventors: Curt Bradshaw, Abhijit Bhat, Jing Yu Lai, Venkata Doppalapudi, Dingguo Liu
  • Patent number: 8293714
    Abstract: The present invention provides VEGF binding peptides. In addition, the invention provides VEGF peptides conjugated to antibodies alone and in conjunction with other anti-angiogenic molecules. Various uses of the peptides and compounds are provided, including methods to treat disorders associated with abnormal angiogenesis.
    Type: Grant
    Filed: April 29, 2009
    Date of Patent: October 23, 2012
    Assignee: Covx Technology Ireland, Ltd.
    Inventors: Venkata Ramana Doppalapudi, Jing-Yu Lai, Bin Liu, Dingguo Liu, Joel Desharnais, Abhijit Suresh Bhat, Yanwen Fu, Bryan Douglas Oates, Gang Chen, Curt William Bradshaw
  • Patent number: 8288349
    Abstract: The present invention provides AA targeting compounds which comprise AA targeting agent-linker conjugates which are linked to a combining site of an antibody. Various uses of the compounds are provided, including methods to treat disorders connected to abnormal angiogenesis.
    Type: Grant
    Filed: November 12, 2007
    Date of Patent: October 16, 2012
    Assignee: Covx Technology Ireland, Ltd.
    Inventors: Curt William Bradshaw, Abhijit Suresh Bhat, Jing-Yu Lai, Venkata R. Doppalapudi, Dingguo Liu
  • Publication number: 20110087010
    Abstract: The present invention provides AA targeting compounds which comprise AA targeting agent-linker conjugates which are linked to a combining site of an antibody. Various uses of the compounds are provided, including methods to treat disorders connected to abnormal angiogenesis.
    Type: Application
    Filed: October 4, 2010
    Publication date: April 14, 2011
    Inventors: Curt W. BRADSHAW, Venkata Ramana DOPPALAPUDI, Jing-Yu LAI, John RIZZO
  • Publication number: 20100003267
    Abstract: The present invention provides VEGF binding peptides. In addition, the invention provides VEGF peptides conjugated to antibodies alone and in conjunction with other anti-angiogenic molecules. Various uses of the peptides and compounds are provided, including methods to treat disorders associated with abnormal angiogenesis.
    Type: Application
    Filed: April 29, 2009
    Publication date: January 7, 2010
    Inventors: Venkata Ramana Doppalapudi, Jing-Yu Lai, Bin Liu, Dingguo Liu, Joel Desharnais, Abhijit Suresh Bhat, Yanwen Fu, Bryan Douglas Oates, Gang Chen, Curt William Bradshaw
  • Patent number: 7521425
    Abstract: The present invention provides AA targeting compounds which comprise AA targeting agent-linker conjugates which are linked to a combining site of an antibody. Various uses of the compounds are provided, including methods to treat disorders connected to abnormal angiogenesis.
    Type: Grant
    Filed: March 3, 2006
    Date of Patent: April 21, 2009
    Assignee: Covx Technologies Ireland Limited
    Inventors: Curt W. Bradshaw, Venkata Ramana Doppalapudi, Jing-Yu Lai, John Rizzo
  • Publication number: 20080262249
    Abstract: Methods of making chiral psorospermin or its analogues and/or intermediates thereof are provided.
    Type: Application
    Filed: August 16, 2005
    Publication date: October 23, 2008
    Inventors: Jeffrey P. Whitten, Jing-Yu Lai
  • Publication number: 20080166364
    Abstract: The present invention provides AA targeting compounds which comprise AA targeting agent-linker conjugates which are linked to a combining site of an antibody. Various uses of the compounds are provided, including methods to treat disorders connected to abnormal angiogenesis.
    Type: Application
    Filed: November 12, 2007
    Publication date: July 10, 2008
    Inventors: Curt Bradshaw, Abhijit Bhat, Jing Yu Lai, Venkata Doppalapudi
  • Publication number: 20080152660
    Abstract: The present invention provides AA targeting compounds which comprise AA targeting agent-linker conjugates which are linked to a combining site of an antibody. Various uses of the compounds are provided, including methods to treat disorders connected to abnormal angiogenesis.
    Type: Application
    Filed: March 3, 2006
    Publication date: June 26, 2008
    Inventors: Curt W. Bradshaw, Venkata Ramana Doppalapudi, Jing-Yu Lai, John Rizzo
  • Publication number: 20060205670
    Abstract: The present invention provides AA targeting compounds which comprise AA targeting agent-linker conjugates which are linked to a combining site of an antibody. Various uses of the compounds are provided, including methods to treat disorders connected to abnormal angiogenesis.
    Type: Application
    Filed: March 3, 2006
    Publication date: September 14, 2006
    Inventors: Curt Bradshaw, Venkata Doppalapudi, Jing-Yu Lai, John Rizzo